
John R Fischer
Odyssey, Permira and THL are among the private equity firms investing in pharma-focused marketing companies.
A roundup of PE investments in medical staffing agencies, which have attracted the likes of Ares Management, Leonard Green & Partners and One Equity Partners; zeroing in on a biopharma merger between the portfolio companies of Odyssey Investment Partners and Permira; insights from a report on private equity healthcare dealmaking in India.
Ares Management, Leonard Green & Partners and One Equity Partners are among the PE firms investing in medical staffing companies.
Bailey & Co, InTandem Capital and TPG see M&A opportunities in revenue cycle management; data sharing; governance, regulation and compliance; and more.
A Q&A with West Monroe’s Beth Mosier and Jeremy Tancredi on how tariff uncertainty could affect healthcare investing; an eight-deal listicle on the fire and life safety services sector; a discussion between Private Equity International and Institutional Limited Partners Association’s Jennifer Choi on LP concerns for US GPs regarding the new administration’s stance on DEI policies.
'Pharma is definitely going to be the hardest hit,' says West Monroe's Jeremy Tancredi.
Avista, BC Partners, Hamilton Lane bet on generic pharma; Changes to US healthcare market already...
Healthcare services M&A is expected to pick up in the coming months, according to new data.
Avista Healthcare Partners, BC Partners, Hamilton Lane and Kartesia are among the PE firms investing in the generic pharmaceutical sector.
Osceola, Renovus and Vistria aim to create regional leaders in end-of-life care.
Private equity bets on footwear.